US Broker Ratings

Agilent Technologies, Inc. (A) Stock Analysis: Potential 8.16% Upside and Robust Revenue Growth

Agilent Technologies, Inc. (NYSE: A) presents a compelling opportunity for investors interested in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $38.73 billion,..

Bio-Techne Corp (TECH) Investor Outlook: Navigating Growth with a 13.65% Potential Upside

Bio-Techne Corp (NASDAQ: TECH) stands out in the biotechnology sector with a robust market capitalization of $9.13 billion. As a prominent player in the healthcare industry, Bio-Techne develops and manufactures..

AstraZeneca PLC (AZN) Stock Analysis: 6.2% Potential Upside Fuels Investor Interest

AstraZeneca PLC (AZN), a stalwart in the healthcare sector, continues to capture investor attention with its robust market position and promising growth potential. Headquartered in Cambridge, United Kingdom, AstraZeneca is..

Baxter International Inc. (BAX) Stock Analysis: A 27.56% Potential Upside with Dividend Yield of 3.10%

Baxter International Inc. (NYSE: BAX) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $11.27 billion, the..

RadNet, Inc. (RDNT) Stock Analysis: Healthcare Diagnostics Firm Poised for Growth with a 12.3% Upside Potential

RadNet, Inc. (NASDAQ: RDNT) stands out in the healthcare diagnostics sector, offering promising growth potential for investors with a recent analyst consensus indicating a potential upside of 12.3%. For investors..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Biotech Terrain with a 68.40% Revenue Growth

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, continues to capture investor interest with its innovative approach to treating rare diseases. Headquartered in Cambridge, Massachusetts, this commercial-stage..

Option Care Health, Inc. (OPCH) Investor Outlook: Analyzing a 41.89% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a key player in the healthcare sector, specifically in medical care facilities, presents an intriguing opportunity for investors seeking growth in a dynamic market...

West Pharmaceutical Services (WST) Stock Analysis: Exploring a 21% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector, has garnered significant attention from investors, and for compelling reasons. With a market capitalization of $18.82 billion,..

Regeneron Pharmaceuticals (REGN) Stock Analysis: A 27.79% Upside Beckons Investors Amidst Biotechnology Innovations

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a heavyweight in the biotechnology sector, offers a compelling narrative for investors seeking exposure to groundbreaking medical innovations. With a market capitalization of $59.84 billion,..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 31% Upside Potential in Transforming Organ Transplantation

TransMedics Group, Inc. (NASDAQ: TMDX), a prominent player in the healthcare sector, is pioneering advancements in organ transplant therapy. With a current market capitalization of $3.66 billion, this Massachusetts-based medical..

Teva Pharmaceutical Industries (TEVA) Rating Update: Assessing a Strong Buy Consensus Amidst a 22% Upside Potential

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the global healthcare arena, has long been a critical player in the specialty and generic drug manufacturing sector. With its roots in..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unpacking a 19.97% Potential Upside for Savvy Investors

Stevanato Group S.p.A. (NYSE: STVN) is making waves in the healthcare sector, particularly in the Medical Instruments & Supplies industry. This Italy-based company, with a robust market capitalization of $6.51..

Insulet Corporation (PODD) Stock Analysis: Exploring a 15.3% Potential Upside with Robust Growth Prospects

Investors looking to capitalize on the growing demand for innovative medical devices might find Insulet Corporation (NASDAQ: PODD) an intriguing prospect. With a market capitalization of $22.14 billion, Insulet operates..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Exploring a 7.67% Potential Upside Amidst Strong Buy Ratings

For investors with an eye on the healthcare sector, iRhythm Technologies, Inc. (NASDAQ: IRTC) presents an intriguing opportunity, especially given the company’s dominant presence in the digital healthcare space. With..

ResMed Inc. (RMD) Stock Analysis: Navigating a 7.83% Potential Upside Amid Healthcare Innovation

ResMed Inc. (NYSE: RMD), a prominent player in the Healthcare sector, operates within the Medical Instruments & Supplies industry, offering a robust portfolio of medical devices and cloud-based software applications..

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 10% Upside Potential in the Diagnostics Sector

Qiagen N.V. (NYSE: QGEN), a global leader in molecular diagnostics and research, offers investors an intriguing opportunity with a potential upside of 10.54%, according to current analyst ratings. As a..

Gilead Sciences (GILD) Stock Analysis: Evaluating a 7.79% Upside Potential in the Healthcare Sector

Gilead Sciences, Inc. (NASDAQ: GILD), a leading player in the healthcare sector, has been at the forefront of biopharmaceutical innovation, particularly in areas of unmet medical need such as HIV/AIDS..

Cardinal Health, Inc. (CAH) Stock Analysis: Exploring the 15.28% Upside Potential

Cardinal Health, Inc. (NYSE: CAH) stands out as a powerhouse in the healthcare sector. With a commanding market capitalization of $37.27 billion, the company is a pivotal player in the..

Masimo Corporation (MASI) Stock Analysis: Exploring a 29.68% Potential Upside in Healthcare Innovation

Masimo Corporation (NASDAQ: MASI) is a significant player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $7.86 billion, Masimo has established itself as..

Quest Diagnostics (DGX) Stock Analysis: Unveiling a 3.05% Potential Upside in the Healthcare Sector

Investors keeping an eye on the healthcare sector would do well to examine Quest Diagnostics Incorporated (NYSE: DGX), a significant player in the diagnostics and research industry. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds